Tal Goldstein

Jun 13, 2024 | tandfonline.com | Marlene Hager |Victoria Fitz |Johannes Ott |Tal Goldstein

ABSTRACTIntroduction In many postmenopausal women, quality of life is decreased due to vasomotor symptoms. Efficient and well-tolerated non-hormonal treatment options are needed. Areas covered The present review summarizes what is known about the etiology of postmenopausal vasomotor symptoms as a rationale for the mechanism of action of Elinzanetant, a new neurokinin (NK)-1/-3 receptor antagonist, as well as its efficacy and side effect profile.

Jul 20, 2023 | weforum.org | Tal Goldstein

SMBs are at an increased risk of cyberattacks, including ones assisted by generative AI. Image: Getty Images/iStockphotoGlobal AgendaThe Agenda WeeklyA weekly update of the most important issues driving the global agendaSubscribe todayYou can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.